IBDEI2LO ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,124,0)
 ;;=TEAM CONFERENCE^9^7
 ;;^UTILITY(U,$J,358.4,125,0)
 ;;=PROLONGED CLINICAL STAFF SERVICES^6^7
 ;;^UTILITY(U,$J,358.4,126,0)
 ;;=ACOUSTIC NERVE INJURIES^1^8
 ;;^UTILITY(U,$J,358.4,127,0)
 ;;=AUDITORY DISORDERS^2^8
 ;;^UTILITY(U,$J,358.4,128,0)
 ;;=BALANCE DISORDERS^3^8
 ;;^UTILITY(U,$J,358.4,129,0)
 ;;=BAROTRAUMA^4^8
 ;;^UTILITY(U,$J,358.4,130,0)
 ;;=EAR DISEASE^5^8
 ;;^UTILITY(U,$J,358.4,131,0)
 ;;=FOREIGN BODIES^5^8
 ;;^UTILITY(U,$J,358.4,132,0)
 ;;=HEARING LOSS^6^8
 ;;^UTILITY(U,$J,358.4,133,0)
 ;;=NOISE INJURIES^7^8
 ;;^UTILITY(U,$J,358.4,134,0)
 ;;=NYSTAGMUS^8^8
 ;;^UTILITY(U,$J,358.4,135,0)
 ;;=OTOTOXICITY^9^8
 ;;^UTILITY(U,$J,358.4,136,0)
 ;;=PURPOSE OF ENCOUNTER/HEALTH STATUS^10^8
 ;;^UTILITY(U,$J,358.4,137,0)
 ;;=NEW PATIENT^2^9
 ;;^UTILITY(U,$J,358.4,138,0)
 ;;=ESTABLISHED PATIENT^1^9
 ;;^UTILITY(U,$J,358.4,139,0)
 ;;=CONSULTATIONS^3^9
 ;;^UTILITY(U,$J,358.4,140,0)
 ;;=NEW PATIENT^2^10
 ;;^UTILITY(U,$J,358.4,141,0)
 ;;=ESTABLISHED PATIENT^1^10
 ;;^UTILITY(U,$J,358.4,142,0)
 ;;=CONSULTATIONS^3^10
 ;;^UTILITY(U,$J,358.4,143,0)
 ;;=ARRYTHMIA^1^11
 ;;^UTILITY(U,$J,358.4,144,0)
 ;;=CHEST PAIN^2^11
 ;;^UTILITY(U,$J,358.4,145,0)
 ;;=CHF/MYOPATHY/TRANSPLANT^3^11
 ;;^UTILITY(U,$J,358.4,146,0)
 ;;=CORONARY ATHEROSCLEROSIS^4^11
 ;;^UTILITY(U,$J,358.4,147,0)
 ;;=GENERAL SYMPTOMS^6^11
 ;;^UTILITY(U,$J,358.4,148,0)
 ;;=HISTORY^9^11
 ;;^UTILITY(U,$J,358.4,149,0)
 ;;=HYPERTENSION/HYPOTENSION^10^11
 ;;^UTILITY(U,$J,358.4,150,0)
 ;;=INFECTION/INFLM DISEASE^11^11
 ;;^UTILITY(U,$J,358.4,151,0)
 ;;=LIPID DISORDER^12^11
 ;;^UTILITY(U,$J,358.4,152,0)
 ;;=MYOCARDIAL INFARCTION^13^11
 ;;^UTILITY(U,$J,358.4,153,0)
 ;;=NONRHEUMATIC HEART VALVE^14^11
 ;;^UTILITY(U,$J,358.4,154,0)
 ;;=HEART DISEASE^7^11
 ;;^UTILITY(U,$J,358.4,155,0)
 ;;=HEART VALVE DISEASE^8^11
 ;;^UTILITY(U,$J,358.4,156,0)
 ;;=PERIPHERAL VASC DISEASE^15^11
 ;;^UTILITY(U,$J,358.4,157,0)
 ;;=RHEUMATIC HEART DISEASE^16^11
 ;;^UTILITY(U,$J,358.4,158,0)
 ;;=DEVICE/IMPLANT/GRAFT^5^11
 ;;^UTILITY(U,$J,358.4,159,0)
 ;;=SYNCOPE^17^11
 ;;^UTILITY(U,$J,358.4,160,0)
 ;;=PACEMAKER^13^12
 ;;^UTILITY(U,$J,358.4,161,0)
 ;;=CORONARY ANGIOPLASTY & STENTS^2^12
 ;;^UTILITY(U,$J,358.4,162,0)
 ;;=ELECTROPHYSIOLOGICAL PROCs^6^12
 ;;^UTILITY(U,$J,358.4,163,0)
 ;;=PERIPHERAL ANGIOPLASTIES & STENTS^14^12
 ;;^UTILITY(U,$J,358.4,164,0)
 ;;=VASCULAR INJECTION PROCs^18^12
 ;;^UTILITY(U,$J,358.4,165,0)
 ;;=OTHER PROCEDURES^12^12
 ;;^UTILITY(U,$J,358.4,166,0)
 ;;=HEART CATHETERIZATIONS^7^12
 ;;^UTILITY(U,$J,358.4,167,0)
 ;;=CATHETERIZATIONS FOR INT RADIOLOGY^1^12
 ;;^UTILITY(U,$J,358.4,168,0)
 ;;=OTHER HEART CODES^11^12
 ;;^UTILITY(U,$J,358.4,169,0)
 ;;=PROSTHETIC ANEURYSM REPAIR^16^12
 ;;^UTILITY(U,$J,358.4,170,0)
 ;;=DEVICE PROGRAMMING^3^12
 ;;^UTILITY(U,$J,358.4,171,0)
 ;;=ECHO^4^12
 ;;^UTILITY(U,$J,358.4,172,0)
 ;;=EKG^5^12
 ;;^UTILITY(U,$J,358.4,173,0)
 ;;=MEDICATION ADMINISTRATION^8^12
 ;;^UTILITY(U,$J,358.4,174,0)
 ;;=MEDICATIONS^9^12
 ;;^UTILITY(U,$J,358.4,175,0)
 ;;=OTHER CARDIAC^10^12
 ;;^UTILITY(U,$J,358.4,176,0)
 ;;=STRESS TESTS^17^12
 ;;^UTILITY(U,$J,358.4,177,0)
 ;;=PREVENTIVE COUNSELING^15^12
 ;;^UTILITY(U,$J,358.4,178,0)
 ;;=NEW PATIENT^2^13
 ;;^UTILITY(U,$J,358.4,179,0)
 ;;=ESTABLISHED PATIENT^1^13
 ;;^UTILITY(U,$J,358.4,180,0)
 ;;=CONSULTATIONS^3^13
 ;;^UTILITY(U,$J,358.4,181,0)
 ;;=MISCELLANEOUS TREATMENT^4^14
 ;;^UTILITY(U,$J,358.4,182,0)
 ;;=CHIROPRACTIC MANIPULATIVE SERVICES^2^14
 ;;^UTILITY(U,$J,358.4,183,0)
 ;;=OSTEOPATHIC MANIPULATIVE TREATMENT^5^14
 ;;^UTILITY(U,$J,358.4,184,0)
 ;;=ACUPUNCTURE^1^14
 ;;^UTILITY(U,$J,358.4,185,0)
 ;;=EDUCATION FOR SELF MGT^3^14
